MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
900
Unique beneficiaries
—
Total services
3,153
Distinct HCPCS
21
Medicare payment
$89K
Peer benchmark
Total Medicare services vs. 130 Endocrinology providers in MN — top quintile (cohort median 631).
PRESCRIBING · PART D · 2024
Total Rx claims
1,965
Beneficiaries
—
Total drug cost
$1.2M
Distinct drugs
28
Brand share
60.6%
Top prescribed drugs
Levothyroxine Sodium265 claims
Insulin Glargine,hum.Rec.Anlog156 claims
Alendronate Sodium141 claims
Metformin Hcl103 claims
Insulin Glargine/Lixisenatide96 claims
QUALITY · MIPS · 2024
Final MIPS score
85.6
Quality
72.5
Cost
77.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.45%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
CROSS-REFERENCE